CATEGORY
Portfolio

Investing in Faks: Transforming the Pharmacy Supply Chain with a Product-Led Network

Written by
Sitar Teli
Managing Partner
SHARE

Investing in Faks: Transforming the Pharmacy Supply Chain with a Product-Led Network

Faks is building a product-based network connecting pharmacies and suppliers, eliminating inefficiencies and unlocking new sales and marketing opportunities for both sides. We’re excited to lead Faks’ €5m seed round alongside our friends at Cocoa, FJ Labs, Seedcamp and others.

Faks fits into our thesis of backing high-velocity product founders who combine network effects and opinionated products to reshape a massive market.

Part 1: Setting the Scene

The pharmacy supply chain is stuck in the past. Sales reps at pharmaceutical suppliers spend 60% of their time on administrative tasks—chasing paperwork, processing orders, and handling claims. Pharmacies juggle hundreds of suppliers and reps using email, spreadsheets, phone calls…and yes, fax machines, instead of modern software. This inefficiency is a massive cost sink for labs, a frustration for pharmacists, and a roadblock to revenue growth.

Founded by Corentin Geoffray (CEO) and Felix Pignard (CTO), Faks is digitizing the pharmacy-supplier relationship, starting with admin automation and expanding into sales enablement.

Part 2: How Faks Works

At its core, Faks streamlines all pharmacy-supplier interactions into a single, digital workflow.

Today: Removing Admin Friction

🔹 Claims Management – Automates issue resolution (e.g., missing discounts, damaged products).

🔹 Expired Product Returns – Digitizes the reimbursement process, replacing paper-based workflows.

🔹 Trade Management – Ensures labs can verify in-store promotions without manual checks.

Tomorrow: Unlocking Sales & Marketing

🚀 Automatic Reordering – Helping labs increase order frequency without manual intervention.

🚀 Offer Targeting – Enabling labs to push personalized promotions directly to pharmacists.

🚀 Ad Network Potential – Creating a targeted ad network by monetizing supplier access.

Why We’re Excited

✅ Network Effects: More pharmacies = more suppliers = more value for both sides.

✅ Product-Led Growth: Pharmacies adopt Faks for free and onboard their suppliers, who in turn onboard their pharmacies.

✅ High Engagement: 7,000+ pharmacies (35% of France) onboarded, with 50% weekly retention.

✅ Massive Market: The pharmacy-supplier relationship spans millions of interactions across Europe.

Part 3: Looking Ahead

Faks isn’t just optimizing sales rep workflows—it’s reinventing how suppliers engage with pharmacies.

With this latest funding, Faks will:

🌍 Expand into new European markets using its lab partnerships.

📈 Scale its pharmacy coverage in France to 90%+.

🛠 Build out its sales & marketing features, unlocking a massive revenue opportunity.

We’re thrilled to support Corentin and Felix as they transform pharmacy sales into a digital-first, product-driven market network.

Related

Sitar Teli
Managing Partner
4th March 2025
Portfolio
Rory Stirling
General Partner
19th February 2025
Portfolio
Pietro Bezza
Managing Partner
11th February 2025
Portfolio
Pietro Bezza
Managing Partner
14th November 2023
Portfolio
See all articles